Formoterol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Formoterol and local guidelines before prescribing.
Mechanism
Long-acting beta-2 agonist with rapid onset.
Uses
Asthma and COPD (maintenance and reliever combined with inhaled steroid).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Tremor, palpitations, headache, hypokalaemia.
Interactions
Beta-blockers antagonise; diuretics and steroids add hypokalaemia.
Contraindications and cautions
Not for acute relief alone
Monitoring
Asthma control, potassium
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
No adjustment
Overdose and reversal
Beta-blocker with caution
Special advice
Used in MART regimens (maintenance and reliever); never alone in asthma.
More from the textbook: uses, cautions and other points
- LABA (long-acting) - salmeterol (slow onset, 12 hours), formoterol ( fast onset , 12 hours - allows use as a reliever in MART/AIR), vilanterol, olodaterol, indacaterol (24 hours).
Respiratory: Anatomy, Physiology and Pharmacology - ICS + LABA - budesonide–formoterol, beclometasone–formoterol, fluticasone–salmeterol, fluticasone furoate–vilanterol.
Respiratory: Anatomy, Physiology and Pharmacology - AIR (anti-inflammatory reliever) - as-needed low-dose ICS–formoterol for mild asthma, instead of a SABA alone.
Respiratory: Anatomy, Physiology and Pharmacology - MART (maintenance and reliever therapy) - the same ICS–formoterol inhaler taken regularly and also as the reliever; escalate to moderate-dose MART if not controlled.
Respiratory: Anatomy, Physiology and Pharmacology - Formoterol is used because its onset is fast; salmeterol combinations can't be used as relievers.
Respiratory: Anatomy, Physiology and Pharmacology - Maximum daily doses of ICS–formoterol must be explained (e.g. no more than 12 puffs a day of budesonide–formoterol 200/6 in most adults - check the product).
Respiratory: Anatomy, Physiology and Pharmacology - Triple therapy (LABA + LAMA + ICS in one inhaler - e.g. fluticasone furoate–umeclidinium–vilanterol, beclometasone–formoterol–glycopyrronium) - COPD with continued exacerbations (especially with raised eosinophils or asthmatic features); severe asthma.
Respiratory: Anatomy, Physiology and Pharmacology - Formoterol / salmeterol (LABA) | Never alone in asthma; formoterol's fast onset allows AIR and MART.
Respiratory: Anatomy, Physiology and Pharmacology
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (11 mentions)
- Respiratory: Investigations (1 mention)
- Respiratory: Airways Disease (9 mentions)
- Paediatrics: Respiratory and heart problems in children (2 mentions)
- Integrated respiratory chapter (8 mentions)
- Integrated paediatrics chapter (2 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)